Chatterjee, D., Tauzin, A., Marchitto, L., Gong, S. Y., Boutin, M., Bourassa, C., Beaudoin-Bussières, G., Bo, Y., Ding, S., Laumaea, A., Vézina, D., Perreault, J., Gokool, L., Morrisseau, C., Arlotto, P., Fournier, É., Guilbault, A., Delisle, B., Levade, I., … Finzi, A. (2022). SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses. Cell Reports, 0(0). https://doi.org/10.1016/j.celrep.2022.110429

Hall, V. G., Ferreira, V. H., Wood, H., Ierullo, M., Majchrzak-Kita, B., Manguiat, K., Robinson, A., Kulasingam, V., Humar, A., & Kumar, D. (2022). Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses. Nature Immunology, 1–6. https://doi.org/10.1038/s41590-021-01126-6

Dr Natalie Shenker on Twitter. (n.d.). Twitter. Retrieved October 13, 2020, from https://twitter.com/DrNShenker/status/1314475759508107265

Devi Sridhar on Twitter: “Lack of evidence is not an excuse for lack of action. Some countries threw everything & the kitchen sink at controlling this virus & protecting their populations. Others spent weeks debating, discussing, producing reports & selling spin, all to get to the perfect evidence-base.” / Twitter. (n.d.). Twitter. Retrieved June 5, 2020, from https://twitter.com/devisridhar/status/1268597763132010497